BlackRock Fund Advisors’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $16.2M | Buy |
305,848
+36,842
| +14% | +$1.96M | ﹤0.01% | 2296 |
|
|
2016
Q3 | $16.3M | Buy |
269,006
+17,849
| +7% | +$1.08M | ﹤0.01% | 2174 |
|
|
2016
Q2 | $16.5M | Buy |
251,157
+11,135
| +5% | +$733K | ﹤0.01% | 2129 |
|
|
2016
Q1 | $13.6M | Buy |
240,022
+987
| +0.4% | +$56K | ﹤0.01% | 2199 |
|
|
2015
Q4 | $56.2M | Sell |
239,035
-11,759
| -5% | -$2.77M | 0.01% | 1395 |
|
|
2015
Q3 | $39.7M | Buy |
250,794
+8,140
| +3% | +$1.29M | 0.01% | 1572 |
|
|
2015
Q2 | $91.8M | Sell |
242,654
-5,272
| -2% | -$1.99M | 0.02% | 1066 |
|
|
2015
Q1 | $104M | Buy |
247,926
+25,144
| +11% | +$10.5M | 0.02% | 969 |
|
|
2014
Q4 | $61M | Buy |
222,782
+20,500
| +10% | +$5.61M | 0.02% | 1322 |
|
|
2014
Q3 | $39.3M | Sell |
202,282
-1,568
| -0.8% | -$305K | 0.01% | 1515 |
|
|
2014
Q2 | $49.9M | Sell |
203,850
-19,487
| -9% | -$4.77M | 0.01% | 1392 |
|
|
2014
Q1 | $59.2M | Buy |
223,337
+13,410
| +6% | +$3.55M | 0.02% | 1289 |
|
|
2013
Q4 | $76.2M | Buy |
209,927
+10,869
| +5% | +$3.95M | 0.02% | 1054 |
|
|
2013
Q3 | $106M | Buy |
199,058
+25,596
| +15% | +$13.6M | 0.04% | 706 |
|
|
2013
Q2 | $40.6M | Buy |
+173,462
| New | +$40.6M | 0.01% | 1378 |
|